Clinical Trials · NCT00434954
Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 494
- Start date
- Feb 2007
- Locations
- 39 sites, Germany
- Primary endpoint
- Change in Glycosylated Hemoglobin (HbA1c)